Phillip B. Donenberg
2016 - Diffusion Pharmaceuticals
In 2016, Phillip B. Donenberg earned a total compensation of $1.2M as Former Chief Financial Officer at Diffusion Pharmaceuticals, a 251% increase compared to previous year.
Compensation breakdown
| Salary | $7,343 |
|---|---|
| Other | $1,192,883 |
| Total | $1,200,226 |
Donenberg received $1.2M in other compensation, accounting for 99% of the total pay in 2016.
Donenberg also received $7.3K in salary.
Rankings
In 2016, Phillip B. Donenberg's compensation ranked 7,370th out of 14,075 executives tracked by ExecPay. In other words, Donenberg earned more than 47.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,370 out of 14,075 | 48th |
Division Manufacturing | 2,785 out of 5,489 | 49th |
Major group Chemicals And Allied Products | 914 out of 1,895 | 52nd |
Industry group Drugs | 711 out of 1,538 | 54th |
Industry Pharmaceutical Preparations | 567 out of 1,176 | 52nd |
Source: SEC filing on May 12, 2017.
Donenberg's colleagues
We found five more compensation records of executives who worked with Phillip B. Donenberg at Diffusion Pharmaceuticals in 2016.
2016
Stephen Simes
Diffusion Pharmaceuticals
Chief Executive Officer
2016
David Kalergis
Diffusion Pharmaceuticals
Chief Executive Officer
2016
Mark Weinberg
Diffusion Pharmaceuticals
Former Senior Vice President, Clinical Development
2016
John Gainer
Diffusion Pharmaceuticals
Chief Scientific Officer
2016
Ben Shealy
Diffusion Pharmaceuticals